METHOD, ARRANGEMENT AND SENSOR FOR NON-INVASIVELY MONITORING BLOOD VOLUME OF A SUBJECT

• US 20090326342A1
• Filed: 06/27/2008
• Published: 12/31/2009
• Est. Priority Date: 06/27/2008
• Status: Abandoned Application

• Current Assignee: General Electric Company
• Original Assignee: General Electric Company
• Inventors: Huiku, Matti
• Application Number:
  US12/163,305
• Publication Number:
  US 20090326342A1
• Time in Patent Office: Days
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

A method, arrangement and sensor for monitoring blood status of a subject are disclosed. In-vivo measurement signals indicative of absorption caused by blood are acquired at a plurality of measurement wavelengths. Based on the in-vivo measurement signals, successive values are determined for a hemoglobin parameter indicative of the concentration of hemoglobin in the blood of the subject and the blood volume status of the subject is monitored based on the successive values. The monitoring may involve determining the absolute value of the blood volume or relative changes in the blood volume. In one embodiment, the absolute value of the blood volume is indicated continuously together with hemoglobin concentration and composition.

Claims

1. A method for monitoring blood volume status of a subject, the method comprising:

acquiring in-vivo measurement signals at a plurality of measurement wavelengths, the in-vivo measurement signals being indicative of absorption caused by blood of a subject;

determining, based on the in-vivo measurement signals, a hemoglobin measure indicative of concentration of hemoglobin in the blood of the subject, wherein the determining includes determining successive values of the hemoglobin measure; and

monitoring, based on the successive values of the hemoglobin measure, the blood volume of the subject.

2. The method according to claim 1, wherein the determining includes

creating an a priori relationship indicative of effect of tissue on the in-vivo measurement signals;

and

determining, based on the a priori relationship, a specific value of the hemoglobin measure for which the effect of the in-vivo tissue on in-vivo measurement signals is consistent for the plurality of measurement wavelengths, the specific value representing a value of the hemoglobin measure, wherein the value is any of the successive values.

3. The method according to claim 2, wherein the creating includes creating the a priori relationship through an in-vivo tissue model including a nominal estimate of the hemoglobin measure.

4. The method according to claim 1, wherein the monitoring includes estimating a value for the blood volume of the subject.

5. The method according to claim 4, wherein the estimating includes

injecting dye substance into the blood of the subject;

determining concentration of the dye substance in the blood of the subject; and

defining the value for the blood volume based on the concentration of the dye substance.

6. The method according to claim 5, wherein the monitoring further includes determining changes in the hemoglobin measure relative to a given time instant at which the value for the blood volume is defined based on the concentration of the dye substance.

7. The method according to claim 1, further comprising determining hemoglobin composition of the subject.

8. The method according to claim 1, wherein the monitoring includes monitoring relative changes in the blood volume of the subject.

9. An arrangement for monitoring blood volume status of a subject, the arrangement comprising:

a signal reception unit configured to receive in-vivo measurement signals corresponding to a plurality of measurement wavelengths, the in-vivo measurement signals being indicative of absorption caused by blood of a subject;

a hemoglobin determination unit configured to determine, based on the in-vivo measurement signals, a hemoglobin measure indicative of concentration of hemoglobin in the blood of the subject, wherein the hemoglobin determination unit is configured to determine successive values of the hemoglobin measure; and

a monitoring unit configured to monitor, based on the successive values of the hemoglobin measure, the blood volume of the subject.

10. The arrangement according to claim 9, further comprising a sensor attachable to the subject, the sensor comprising:

an emitter unit configured to emit radiation through tissue of the subject at the plurality of measurement wavelengths;

a detector unit configured receive the radiation and to produce the in-vivo measurement signals corresponding to the plurality of wavelengths.

11. The arrangement according to claim 9, wherein the hemoglobin determination unit is configured to

retrieve an a priori relationship indicative of effect of tissue on in-vivo measurement signals at the plurality of measurement wavelengths;

and

determine, based on the a priori relationship, a specific value of the hemoglobin measure for which the effect of the in-vivo tissue on in-vivo measurement signals is consistent for the plurality of measurement wavelengths, the specific value representing a value of the hemoglobin measure, wherein the value is any of the successive values.

12. The arrangement according to claim 11, wherein the a priori relationship is created through an in-vivo tissue model including a nominal estimate of the hemoglobin measure.

13. The arrangement according to claim 9, wherein the monitoring unit is configured to estimate a value for the blood volume of the subject.

14. The arrangement according to claim 13, wherein the monitoring unit is configured to

determine concentration of a dye substance in blood of the subject;

and

define the value for the blood volume based on the concentration of the dye substance.

15. The arrangement according to claim 14, wherein the monitoring unit is further configured to determine changes in the hemoglobin measure relative to a given time instant at which the value for the blood volume is defined based on the concentration of the dye substance.

16. The arrangement according to claim 13, wherein the monitoring unit is further configured to determine hemoglobin composition of the subject and the monitoring unit comprises a display for displaying the hemoglobin concentration, hemoglobin composition, and blood volume.

17. The arrangement according to claim 9, wherein the monitoring unit is configured to monitor relative changes in the blood volume of the subject.

18. A sensor for determining blood volume status of a subject, the sensor being attachable to the subject and comprising:

an emitter unit configured to emit radiation through the tissue of the subject at a plurality of measurement wavelengths;

a detector unit configured to receive the radiation and to produce in-vivo measurement signals corresponding to the plurality of measurement wavelengths, wherein the in-vivo measurement signals are indicative of absorption caused by blood of the subject;

a hemoglobin determination unit configured to determine, based on the in-vivo measurement signals, a hemoglobin measure indicative of concentration of hemoglobin in the blood of the subject, wherein the hemoglobin determination unit is configured to determine successive values of the hemoglobin measure;

an interface unit configured to send the successive values of the hemoglobin measure to an external unit configured to monitor the blood volume of the subject based on the successive values.

19. An apparatus for monitoring blood volume status of a subject, the apparatus comprising:

a reception unit configured to receive successive values of a hemoglobin measure indicative of hemoglobin concentration in blood of a subject; and

a monitoring unit configured to monitor, based on the successive values of the hemoglobin measure, the blood volume of the subject.

20. A computer program product for monitoring blood volume status of a subject, the computer program product comprising:

a first program product portion configured to receive in-vivo measurement signals corresponding to a plurality of measurement wavelengths, the in-vivo measurement signals being indicative of absorption caused by blood of a subject;

a second program product portion configured to determine, based on the in-vivo measurement signals, successive values of a hemoglobin measure indicative of hemoglobin concentration in the blood of the subject; and

a third program product portion configured to indicate, based on the successive values, blood volume status of the subject.